White Paper
Nothing About Us Without Us
The rare disease community has long held that decisions about rare diseases should involve the people who live with them. This white paper explores how the "nothing about us without us" principle translates into practice for pharma engagement strategies — and why integrating patient voice isn't just ethical, it produces better physician education outcomes.
What’s Inside
- The origins and evolution of the "nothing about us without us" principle in rare disease
- How patient advocacy organizations shape HCP education priorities
- Practical frameworks for integrating patient voice into physician engagement programs
- The measurable impact of patient-informed content on HCP engagement depth
